1997
DOI: 10.1023/a:1018376717545
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1999
1999
2003
2003

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…One approach relies on the construction of a polyantigenic vaccine from the admixture of several existing monoantigenic conjugate vaccines, in either clustered or non-clustered form [31,89]. This idea has been used extensively in fields outside of cancer (e.g., bacterial vaccines) [90,91]. Preclinical trials using polymolecular glycoconjugates have demonstrated the viability of this method.…”
Section: Polyantigenic Clustered Vaccinesmentioning
confidence: 99%
“…One approach relies on the construction of a polyantigenic vaccine from the admixture of several existing monoantigenic conjugate vaccines, in either clustered or non-clustered form [31,89]. This idea has been used extensively in fields outside of cancer (e.g., bacterial vaccines) [90,91]. Preclinical trials using polymolecular glycoconjugates have demonstrated the viability of this method.…”
Section: Polyantigenic Clustered Vaccinesmentioning
confidence: 99%